Sanofi CFO Jérôme Contamine Comments on Q1 2012 Results

PARIS--()--Sanofi, a global and diversified healthcare leader, reports earnings for the first-quarter of 2012. Jérôme Contamine, Chief Financial Officer of Sanofi, comments on results and outlook.

Click to watch the video:

http://www.eurobusinessmedia.com/Sanofi-CFO-Jerome-Contamine-comments-on-Q1-2012-results?utm_source=ceo-direct&utm_medium=bw

Topics covered in the interview include:

- Q1 2012 Results

- Genzyme

- Diabetes

- Flagship Brands

- R&D Pipeline

- Debt

- Guidance

About Sanofi

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Company website: www.sanofi.com

Contacts

Sanofi

Investor Relations

Sébastien Martel, +33 1 53 77 45 45

IR@sanofi.com

or

Media Relations

+33 1 53 77 45 02

MR@sanofi.com

Release Summary

Sanofi, a global and diversified healthcare leader, reports earnings for the first-quarter of 2012. Jérôme Contamine, CFO of Sanofi, comments on results and outlook

Sharing

Contacts

Sanofi

Investor Relations

Sébastien Martel, +33 1 53 77 45 45

IR@sanofi.com

or

Media Relations

+33 1 53 77 45 02

MR@sanofi.com